Guardant Health Q3 2023

And some interesting news on GH Shield

Guardant Health GH 0.00%↑ presented results and there are some interesting news on the use of their SHIELD early CRC detection method, which uses cfDNA epiprofiling to detect fragments of DNA coming from cancerous cells in the colon/rectum.

The numbers for Q3, coming from Genomeweb:

Revenue was $143.0 million for the three months ended Sept. 30, compared to $117.4…